BTG plc, a specialty pharmaceuticals company, engages in the development and commercialization of life science technologies primarily in the United States, Europe, and Asia. It focuses on medicines that are used in critical care situations, and to treat cancer, neurological, and other disorders.

Acquired Companies: Protherics Plc, Biocompatibles International